Why we still believe in Wise

24/01/23 -"Wise’s share price keeps on plummeting following its Q3 23 trading update, in which it raised its guidance hugely. We remain convinced that the Volume Per Customer (VPC) variation seen in Q3 23 is ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

24/01/23

Download

You may also be interested by these reports :

02/02/23

DWS

• Net profit decreased by 57% to €111m for Q4 22 compared to Q4 21 • Net new money outflow was €1.6bn in Q4 22 compared to an inflow of €15bn for Q4 ...

02/02/23

KINNEVIK INVESTMENT

Unsurprisingly, the narrative does not change for Kinnevik in Q4 as it continues to be plagued by macro-economic headwinds, inflation, rising rates ...

31/01/23

WORLDLINE

Worldline has released the company-compiled consensus for Q4 22. The figures have been trending downwards since the start of 2022. We confirm our ...

30/01/23

HBM HEALTHCARE INVESTMENTS

CEO Andreas Wicki takes a leave of absence

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue